Vitale, G.; Carra, S.; Alessi, Y.; Campolo, F.; Pandozzi, C.; Zanata, I.; Colao, A.; Faggiano, A.; on behalf of the NIKE Group.
Carcinoid Syndrome: Preclinical Models and Future Therapeutic Strategies. Int. J. Mol. Sci. 2023, 24, 3610.
https://doi.org/10.3390/ijms24043610
AMA Style
Vitale G, Carra S, Alessi Y, Campolo F, Pandozzi C, Zanata I, Colao A, Faggiano A, on behalf of the NIKE Group.
Carcinoid Syndrome: Preclinical Models and Future Therapeutic Strategies. International Journal of Molecular Sciences. 2023; 24(4):3610.
https://doi.org/10.3390/ijms24043610
Chicago/Turabian Style
Vitale, Giovanni, Silvia Carra, Ylenia Alessi, Federica Campolo, Carla Pandozzi, Isabella Zanata, Annamaria Colao, Antongiulio Faggiano, and on behalf of the NIKE Group.
2023. "Carcinoid Syndrome: Preclinical Models and Future Therapeutic Strategies" International Journal of Molecular Sciences 24, no. 4: 3610.
https://doi.org/10.3390/ijms24043610
APA Style
Vitale, G., Carra, S., Alessi, Y., Campolo, F., Pandozzi, C., Zanata, I., Colao, A., Faggiano, A., & on behalf of the NIKE Group.
(2023). Carcinoid Syndrome: Preclinical Models and Future Therapeutic Strategies. International Journal of Molecular Sciences, 24(4), 3610.
https://doi.org/10.3390/ijms24043610